IBUGESIC Film-coated tablet Ref.[50642] Active ingredients: Ibuprofen

Source: Medicines and Medical Devices Safety Authority (NZ)  Revision Year: 2021  Publisher: Rex Medical Limited, PO Box 18-119, Glen Innes, Auckland Telephone (09) 574 6060

Product name and form

IBUGESIC.

Pharmaceutical Form

White to off-white circular biconvex film coated tablets, plain on both sides.

Qualitative and quantitative composition

Ibuprofen tablets 200 mg.

Active Ingredient Description
Ibuprofen

Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation.
List of Excipients

Hypromellose
Propylene glycol
Purified talc
Titanium dioxide
Colloidal silicon dioxide
Magnesium stearate
Maize starch
Sodium laurilsulfate

Pack sizes and marketing

Ibugesic tablets are available in PVC/Al blister packs of 120 and 1000 tablets.

Marketing authorization holder

Rex Medical Limited, PO Box 18-119, Glen Innes, Auckland
Telephone (09) 574 6060

Marketing authorization dates and numbers

Date of first approval: 10 April 2014

Drugs

Drug Countries
IBUGESIC Ecuador, New Zealand, South Africa
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈